Vecchiarelli A, Verducci G, Perito S, Puccetti P, Marconi P, Bistoni F
J Antibiot (Tokyo). 1986 Jun;39(6):846-55. doi: 10.7164/antibiotics.39.846.
We have recently reported the in vivo augmentation of resistance to experimental Candida albicans injection by amphotericin B in mice and have shown that this event is concurrent with the appearance in the spleen of a highly candidacidal cell population reactive in vitro against 51Cr-labeled yeast cells. In the present study we characterize these in vitro fungicidal effectors as macrophages and describe the conditions of amphotericin B treatment most suitable for inducing candidacidal activity. We also report that macrophages from intact mice can be activated in vitro to become cytotoxic against Candida. The possible mechanisms through which the amphotericin B activated macrophages exert their increased anti-Candida activity are also investigated.
我们最近报道了两性霉素B在小鼠体内增强对实验性白色念珠菌注射的抵抗力,并且表明这一现象与脾脏中出现的一种高度杀念珠菌细胞群同时发生,该细胞群在体外对51Cr标记的酵母细胞具有反应性。在本研究中,我们将这些体外杀真菌效应细胞鉴定为巨噬细胞,并描述了最适合诱导杀念珠菌活性的两性霉素B治疗条件。我们还报告说,来自未受损小鼠的巨噬细胞可以在体外被激活,从而对念珠菌产生细胞毒性。我们还研究了两性霉素B激活的巨噬细胞发挥增强的抗念珠菌活性的可能机制。